Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial

詳細情報 詳細情報について

• CRID

  1360855570554742784

• DOI

  10.1136/ard.2010.143974

• ISSN

  00034967

• Web Site

  https://api.elsevier.com/content/article/PII:S0003496724100982?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0003496724100982?httpAccept=text/plain

  https://syndication.highwire.org/content/doi/10.1136/ard.2010.143974

• データソース種別

  • Crossref